BEIJING — China’s two major COVID-19 vaccine makers have signed agreements to provide up to 550 million doses to COVAX, the U.N.-backed program that aims to deliver vaccines to poor countries and others that need them.
Gavi, the vaccine partnership playing a leading role in COVAX, announced that it would buy 110 million doses from Sinopharm and Sinovac between now and October. In addition, it has the option to buy 440 million more doses by mid-2022.
The World Health Organization has approved the companies’ vaccines for emergency use. Their inactivated vaccines are already in widespread use in China and in many other countries.
Inactivated vaccines are made with killed coronavirus. Most other COVID vaccines in use, particularly in the West, are made with newer technologies that target the “spike” protein that coats the surface of the virus.
LONDON (AP) — A mammoth three-year public inquiry into the U.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.06 USD
